The Molecular Medicine Tri-Conference has been and will continue to be a platform in recognizing the potential for emerging therapeutic, diagnostic, and technology approaches to advance precision medicine. The Tri-Conference unites an ecosystem of over 3,100 innovative thinkers and thought leaders in the field of drug discovery, development and diagnostics, informatics, and digital health throughout pharma, biotech, and academia from around the world. The Tri-Conference remains one of the key industry meetings covering the latest trends, technologies, research breakthroughs, regulatory issues, and best practice examples of molecular and translational medicine advances, digital health, and bio-it.
Former plenary keynote speakers have included:
- Kimberly L. Blackwell, MD, Professor of Medicine, Assistant Professor of Radiation Oncology; Director, Breast Cancer Program, Duke Cancer Institute
- C. Thomas Caskey, MD, FACP, FRSC, Professor, Department of Molecular and Human Genetics, Baylor College of Medicine
- Jocalyn Clark, PhD, Associate Editor, British Medical Journal (now Executive Director, The Lancet)
- John F. Crowley, Founder, Novazyme Pharmaceuticals, Inc. (now Chairman & CEO at Amicus Therapeutics)
- Kevin Davies, PhD, Author, The $1,000 Genome; Editor-in-Chief, Bio-IT World (now Executive VP and Editor, CRISPR Journal)
- Dave Dravecky, Former Pitcher, San Francisco Giants and Cancer Survivor
- David Ewing Duncan, Chief Correspondent of NPR Talk’s “Biotech Nation” and best-selling Author, “Masterminds”
- Kathleen Gallagher, Reporter, Milwaukee Journal Sentinel; Co-Author, One in a Billion: The Story of Nic Volker and the Dawn of Genomic Medicine
- Sarah Gray, Author, A Life Everlasting: The Extraordinary Story of One Boy’s Gift to Medical Science
- Arupa Ganguly, PhD, Professor of Genetics, Perelman School of Medicine, University of Pennsylvania
- Rick Guidotti, Director, Positive Exposure
- David Haussler, PhD, Distinguished Professor and Scientific Director, UC Santa Cruz Genomics Institute, University of California, Santa Cruz
- Leroy Hood, MD, PhD, President and Co-Founder, Institute for Systems Biology; Senior Vice President & CSO, Providence St. Joseph Health
- Kenneth Kaitin, PhD, Director, Tufts Center for Study of Drug Development
- Michael Karin, PhD, Distinguished Professor of Pharmacology, University of California, San Diego School of Medicine
- Stephen F. Kingsmore, MB, ChB, BAO, DSc, FRCPath, President and CEO, Rady Pediatric Genomics & Systems Medicine Institute at Rady Children’s Hospital, San Diego
- Jonathan Peck, Vice President, Institute for Alternative Futures
- Jonathan M. Rothberg, PhD, Founder, CEO and Chairman, Ion Torrent (now Founder and Chairman, LAM Therapeutics and Adjunct Professor of Genetics, Yale School of Medicine)
- Amylynne Santiago Volker, Founder, Nicholas Volker One In A Billion Foundation
- Eric Schadt, PhD, Director of the Icahn Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences; Jean C. and James W. Crystal Professor of Genomics, Icahn School of Medicine at Mount Sinai
- Paul J.H. Schoemaker, PhD, MBA, Chairman and Chief Executive Officer, Decision Strategies International, Inc.; Research Director, Mack Center for Technological Innovation, The Wharton School; Adjunct Professor of Marketing, The Wharton School Adjunct Professor, Wharton School of Business (now Chairman of Public Salt, Inc. and Senior Fellow at Wharton)
- Gary W. Small, MD, Parlow-Solomon Professor on Aging, Professor of Psychiatry & Biobehavioral Sciences, Director, UCLA Center on Aging, Director, Memory & Aging Research Center, Director, Geriatric Psychiatry Division, Semel Institute for Neuroscience & Human Behavior, David Geffen School of Medicine at UCLA
- Jorge Soto, Co-Founder and CTO, Miroculus
- Liz Worthey, PhD, Faculty Investigator and Director, Software Development & Informatics, HudsonAlpha Institute for Biotechnology (now Founder and Chief Informatics & Product Development Officer, Envision Genomics; Section Head, Director, and Associate Professor, UAB SOM depts of Pathology and Pediatrics, UAB School of Medicine)
In 2020, the Molecular Medicine Tri-Conference will change its plenary keynote session. One plenary keynote presentation will be held on Monday March 2 from 5:00-6:00 pm. Approximately 1,000 people will attend, making it the only time where attendees from all 17 conference programs come together in one room. The topic and speaker we choose will speak on a topic relevant to participants attending our three core conferences: Conference 1: Precision Health, Conference 2: Digital Health, and Conference 3: Bio-IT World Conference & Expo WEST. Visit here for finer details on our core conferences.
Outside of the plenary session, attendees will have opportunities to gather within their core conference to hear keynote presenters and topics relevant to their area of programming.
Please visit this page during the August-September time frame for further developments.